Document Detail


Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial.
MedLine Citation:
PMID:  21362684     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The evidence underpinning the timing of an oocyte collection in IVF or ICSI is limited. The aim of this study was to assess the effect of the follicle diameter size of the dominant follicle on ongoing pregnancy rates.
METHODS: We conducted a randomized controlled trial, including women aged between 18 and 43 years who were scheduled for GnRH agonist down-regulated IVF/ICSI treatment in four assisted conception units. Women were randomized between timing oocyte collection when the leading follicle had a diameter of 22 mm or when the leading follicle had a diameter of 18 mm. The primary end-point was ongoing pregnancy, defined as a viable pregnancy at 12 weeks of gestation.
RESULTS: The trial had major problems with recruiting patients and after the planned 2 years of recruiting only half of the aimed 400 inclusions were obtained. We allocated 97 women to the 22-mm group and 93 women to the 18-mm group. In the 22-mm group more women reached an ongoing pregnancy (37 of 97 women, 38%) compared with the 18-mm group (22 of 93 women, 24%) resulting in a relative risk of 1.6 [95% confidence interval (CI): 1.03-2.5]. In a logistic regression analysis, the timing of oocyte collection, adjusted for female age, IVF/ICSI and centre, was still associated with ongoing pregnancy, although the association was no longer statistically significant (OR: 2.0; 95% CI: 0.96-4.2) CONCLUSIONS: This study suggests that delaying the timing of oocyte collection in IVF or ICSI results in better ongoing pregnancy rates, however, larger studies have to be performed to prove or refute these findings.
TRIAL REGISTRATION: ISRCTN24724622.
Authors:
M H Mochtar; I M Custers; C A M Koks; R E Bernardus; H R Verhoeve; B W Mol; M van Wely; F van der Veen
Related Documents :
9290474 - Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed high-dose oral dex...
24883294 - A meningomyelocele with normal intracranial signs on ultrasound and false-negative amni...
23104794 - First-trimester reference ranges for decidual thickness and its relation to progesteron...
11702904 - Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
10063234 - Fertility outcome after reversal of sterilization.
6462574 - Use of the hand-held calculator in office ultrasound.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2011-02-28
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  26     ISSN:  1460-2350     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-20     Completed Date:  2011-08-12     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  1091-6     Citation Subset:  IM    
Data Bank Information
Bank Name/Acc. No.:
ISRCTN/ISRCTN24724622
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Down-Regulation
Female
Fertilization in Vitro
Gonadotropin-Releasing Hormone / agonists*
Humans
Oocyte Retrieval / methods*
Ovarian Follicle / anatomy & histology,  growth & development
Pregnancy
Pregnancy Rate
Regression Analysis
Sperm Injections, Intracytoplasmic
Time Factors
Chemical
Reg. No./Substance:
33515-09-2/Gonadotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Looking downstream: a review of the literature on physical and psychosocial health outcomes in adole...
Next Document:  Preconceptional genetic carrier testing and the commercial offer directly-to-consumers.